Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

uniQure NV (QURE)

  • Business News
  • Dec. 17, 2025, 01:53 UTC
  • 17
  • 1 comments

QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Dec. 17, 2025, 00:37 UTC
  • 19
  • 1 comments

[Press Release] HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors

Market reaction Comment Full text

Annexon Inc (ANNX)

  • Business News
  • Dec. 17, 2025, 00:31 UTC
  • 15
  • 1 comments

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Dec. 17, 2025, 00:00 UTC
  • 14
  • 1 comments

HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors

Market reaction Comment Full text

ResMed Inc (RMD)

  • Business News
  • Dec. 16, 2025, 23:32 UTC
  • 14
  • 1 comments

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Dec. 16, 2025, 22:12 UTC
  • 14
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Dec. 16, 2025, 22:12 UTC
  • 16
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Dec. 16, 2025, 21:36 UTC
  • 17
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Dec. 16, 2025, 21:36 UTC
  • 14
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Dec. 16, 2025, 21:22 UTC
  • 18
  • 1 comments

Becoming a substantial holder

Market reaction Comment Full text
  • Previous
  • 305
  • 306
  • 307
  • 308
  • 309
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2315)
  • SEC News(190434)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124845)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin